BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7029926)

  • 1. [Pathogenetic mechanism and clinical relevance of acquired anti-thrombin III deficiency in internal medicine (author's transl)].
    Thaler E
    Wien Klin Wochenschr; 1981 Oct; 93(18):563-72. PubMed ID: 7029926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antithrombin III deficiency and tendency to thrombosis (author's transl)].
    Lechner K; Thaler E; Niessner H; Nowotny C; Partsch H
    Wien Klin Wochenschr; 1977 Apr; 89(7):215-22. PubMed ID: 857429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe antithrombin III deficiency in an infant associated with multiple arterial and venous thromboses.
    Mendelsohn G; Gomperts ED; Gurwitz D
    Thromb Haemost; 1976 Dec; 36(3):495-502. PubMed ID: 65797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antithrombin III in 86 patients with venous thrombosis (author's transl)].
    Juillet Y; Aiach M; Fiessinger JN; Leclerc M; Housset E
    Sem Hop; 1978 Nov 8-15; 54(37-40):1126-9. PubMed ID: 217091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acquired antithrombin III deficiency].
    Müller G
    Z Gesamte Inn Med; 1992 Feb; 47(2):74-7. PubMed ID: 1585693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substitution of antithrombin III.
    Breddin HK; Kirchmaier CM
    Wien Klin Wochenschr; 1984 Dec; 96(24):875-9. PubMed ID: 6528616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of the development of acquired antithrombin III deficiency in the experimental nephrotic syndromes.
    Bashkov GV; Kalishevskaya TM; Strukova SM
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):324-8. PubMed ID: 2465224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
    Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
    Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical studies on plasma antithrombin III using an antiserum prepared in our laboratories.
    Cucuianu M; Cristea A; Vonica A; Lascu I
    Med Interne; 1988; 26(3):191-7. PubMed ID: 3187359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical importance of the determination of antithrombin III by the use of a chromogenic substrate, in cases of disseminated intravascular coagulation and of acute hepatic insufficiency].
    Carmignoto F; Schivo P; Plebani M; Pengo V; Piccini P; Ceriotti G
    Quad Sclavo Diagn; 1981 Jun; 17(2):172-81. PubMed ID: 7267980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antithrombin III in various conditions in internal medicine].
    Malý J; Pecka M; Pidrman V; Zadák Z; Gregor J; Jebavý L; Bláha M; Siroký O
    Vnitr Lek; 1997 Oct; 43(10):645-8. PubMed ID: 9601877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin III deficiency, deep venous thrombosis, and oral contraceptive use.
    Werner MJ
    J Adolesc Health; 1995 Sep; 17(3):189-92. PubMed ID: 8519788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antithrombin III determination in horses. Reference values and acquired antithrombin III deficiency].
    Gerhards H
    Tierarztl Prax; 1987; 15(1):47-55. PubMed ID: 3590168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Replacement therapy of acquired antithrombin III deficiency in experimental nephrotic syndrome].
    Bashkov GV; Kalishevskaia TM
    Biull Eksp Biol Med; 1987 Sep; 104(9):278-81. PubMed ID: 3663906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin III deficiency: clinical relevance and replacement therapy.
    Gallus AS
    Dev Biol Stand; 1987; 67():59-66. PubMed ID: 3609485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical aspects of acquired antithrombin III deficiency].
    von Blohn G; Hellstern P; Köhler M; Scheffler P; Wenzel E
    Behring Inst Mitt; 1986 Feb; (79):200-15. PubMed ID: 3718407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of antithrombin III in kidney diseases].
    Schrader J; Köstering H; Scheler F
    Behring Inst Mitt; 1986 Feb; (79):216-30. PubMed ID: 3718408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assay of dermatan sulfate cofactor (heparin cofactor II) activity in human plasma.
    Abildgaard U; Larsen ML
    Thromb Res; 1984 Aug; 35(3):257-66. PubMed ID: 6547786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recurrent familial thromboembolic disease due to congenital deficiency in anti-thrombin III. Preliminary study of 3 cases (author's transl)].
    Dayan L; Donadio D; David E; Huguet M
    Nouv Presse Med; 1978 Oct; 7(36):3229-31. PubMed ID: 733487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [L-asparaginase, antithrombin III deficiency and thromboses (author's transl)].
    Bordigoni P; Briquel E; Olive D
    Arch Fr Pediatr; 1981 Nov; 38(9):653-5. PubMed ID: 6949499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.